SME support to evaluate innovative medical technologies: round 4
Published on 07/05/2019
SMEs can apply for a share of £1.5 million to support the evaluation of innovative medical devices, diagnostics and regulated digital health products.
Total project costs of up to £50,000 for option 1.
Up to £250,000 for option 2.
Projects must start by 1 January 2019 and be completed by the end of December 2019.
You could get funding of up to 50% of your eligible project costs.
SMEs are encouraged to get involved in the development and manufacture of innovative medical devices, diagnostics and regulated digital healthcare products. This competition is to collect supporting clinical evidence on the performance and impact of their product in the NHS.
Your proposal must:
- describe the innovative medicine or CE-marked device
- show how your product is likely to have a significant impact, including increasing patient access to innovative technologies where appropriate
- include any up to date evidence of the product’s clinical performance and cost effectiveness
- demonstrate how the product meets the priority needs defined in Next steps on the NHS 5 Year Forward View, and how it is expected to deliver significant cost savings, health gains or beneficial service impacts if quickly adopted across NHS England
- provide evidence that you are working with appropriate stakeholders including NICE, NHS England, NIHR and AHSNs
- include the development or implementation of plans for data collection within the NHS
- outline how studies will generate data on the costs and benefits of a product, allowing evaluation by NICE
Your project must:
- focus on understanding evidence gaps and testing product performance to explain the operational impact of your product on the NHS
- produce evidence of the impact of your technology
- expand the evidence base by adding data that can contribute to the health technology appraisal process, for instance by comparing the use of the new product with the current standard of care
- support identification of potential breakthrough technologies
- support the establishment of improved methods and systems, and demonstrate how the product combined with health care system adaptation delivers better outcomes at lower cost
Priority will be given to projects that:
- reduce cancellations or unnecessary appointments in primary and secondary care
- reduce the burden on A&E services, for example by diverting footfall
- improve patient safety and avoid patient harm
- speed up diagnosis, such as improving the scope of lower cost diagnostic imaging
- enable earlier diagnosis of cancer
- support the management of long term conditions, such as diabetes, chronic pain management cardiovascular disease, asthma and chronic obstructive pulmonary disease (COPD)
Application deadline: 12pm (noon) 3rd July 2019.
If you could benefit from this funding call, please contact a member of the Abbey Funding Team on 0114 236 4457 to discuss eligibility and how to apply.